<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02008825</url>
  </required_header>
  <id_info>
    <org_study_id>SLHN2013-62</org_study_id>
    <nct_id>NCT02008825</nct_id>
  </id_info>
  <brief_title>Evaluation of the ViSiGiTM Calibration System</brief_title>
  <acronym>ViSiGi</acronym>
  <official_title>Evaluation of the ViSiGiTM Calibration System for Effectiveness With Sleeve Visual Delineation at Various Suction Levels.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's Hospital and Health Network, Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Luke's Hospital and Health Network, Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that using the ViSiGi™ Calibration Tube System in patients undergoing LSG&#xD;
      will:&#xD;
&#xD;
        1. enhance delineation of the stomach anatomy and the surgeon's appreciation of the extent&#xD;
           of gastric volume to be removed;&#xD;
&#xD;
        2. increase the safety profile of the patient (i.e., reduce the likelihood of accidental&#xD;
           stapling of the orogastric tube or bougie);&#xD;
&#xD;
        3. reduce the incidence of OR contamination/infection transmission;&#xD;
&#xD;
        4. streamline OR workflow, resulting in reduced OR time; and&#xD;
&#xD;
        5. ensure consistent and reproducible staple lines.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic Sleeve Gastrectomy (LSG), is now widely used as a stand-alone procedure for&#xD;
      long-term weight loss. With fewer potential morbidities, comparable weight loss and greater&#xD;
      ease of conversion to other procedures, many patients now opt for LSG as their bariatric&#xD;
      procedure of choice. During surgery gastric decompression and calibration are compulsory for&#xD;
      patient safety, gastric anatomic delineation, ease of surgery and optimal weight loss. The&#xD;
      removed gastric volume at surgery seems to predict the procedure's success rates2. LSG&#xD;
      performed without calibration (tube) could result in inconsistent staple lines, with retained&#xD;
      high sleeve volume and consequent failure. Traditionally, although different tubes are used&#xD;
      for gastric decompression and calibration, this protocol interrupts operation room (0R)&#xD;
      workflow. Accidental stapling of orogastric tubes and bougies do occur in the OR but are&#xD;
      seldom reported. The need for this multiple tube system can be obviated with the ViSiGi™&#xD;
      Calibration Tube System. A single, multipurpose tube that integrates all these various steps&#xD;
      could prevent breaks in OR; improve workflow; reduce patient injuries, cross contamination&#xD;
      and transmission of infections; and a consistent and reproducible staple line. A similar&#xD;
      device has been in use in Europe, Australia and Asia, but the ViSiGi™ Calibration Tube System&#xD;
      is the first of its kind to be approved by the FDA. Currently, there are no data on its&#xD;
      clinical safety/efficacy in comparison to standard care of separate orogastric tube and&#xD;
      bougie in the United States. Therefore, this exploratory study will investigate the gastric&#xD;
      delineation ability, general safety and efficacy of the ViSiGi™ Calibration Tube System along&#xD;
      with the regular bougie in LSG patients over a six- to twelve-month period. Descriptive&#xD;
      outcomes will be reported, with no formal sample size calculation in light of the exploratory&#xD;
      study design.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficasy</measure>
    <time_frame>3 months</time_frame>
    <description>This exploratory study will investigate the gastric delineation ability, general safety and efficacy of the ViSiGi™ Calibration Tube System along with the regular bougie in LSG patients over a six- to twelve-month period. Descriptive outcomes will be reported, with no formal sample size calculation in light of the exploratory study design.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Enhance Delineation of the Stomach Anatomy and the Surgeon's Appreciation of the Extent of Gastric Volume to be Removed;</condition>
  <condition>Increase the Safety Profile of the Patient (i.e., Reduce the Likelihood of Accidental Stapling of the Orogastric Tube or Bougie);</condition>
  <condition>Reduce the Incidence of OR Contamination/Infection Transmission;</condition>
  <condition>Streamline OR Workflow, Resulting in Reduced OR Time</condition>
  <condition>Ensure Consistent and Reproducible Staple Lines.</condition>
  <arm_group>
    <arm_group_label>ViSiGi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Utilization of ViSiGi calibration tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual non suction Bougie</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Utilization of ViSiGi calibration tube</intervention_name>
    <description>Utilization of ViSiGi calibration tube</description>
    <arm_group_label>ViSiGi</arm_group_label>
    <other_name>ViSiGi 3D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Usual non suction Bougie</intervention_name>
    <description>Usual non suction Bougie</description>
    <arm_group_label>Usual standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ability to provide written informed consent for study participation.&#xD;
&#xD;
          -  age 18 years or older&#xD;
&#xD;
          -  candidate for laparosopic gastrectomy with no history of previous bariatric surgeries&#xD;
             (i.e., gastric bypass, band, duodenal switch)attendance at an informational seminar&#xD;
             and support group&#xD;
&#xD;
          -  clearance for surgery by a registered dietician and certified social worker&#xD;
&#xD;
          -  BMI &gt; 35 with at least one co-morbid condition (e.g., hypertension, diabetes mellitus,&#xD;
             sleep apnea, hypercholesterolemia) or BMI &gt; 40 without any co-morbid conditions&#xD;
&#xD;
          -  negative pregnancy test&#xD;
&#xD;
          -  American Society of Anesthesiology score 1-3&#xD;
&#xD;
          -  ability to understand instructions and comply with all study requirements&#xD;
&#xD;
          -  pre-operative %excess weight loss (%EWL) of 3-10%&#xD;
&#xD;
          -  no contraindication for LSG based on upper endoscopy findings&#xD;
&#xD;
          -  pre-operative cardiac consultation for risk stratification&#xD;
&#xD;
          -  evaluation by a sleep medicine specialist to identify risk factors for sleep apnea,&#xD;
             with treatment as deemed appropriate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current participation in another clinical trial that involves any investigational drug&#xD;
             or device that would interfere with this study&#xD;
&#xD;
          -  Barrett's Esophagus, severe gastric paresis/atony, achalasia, neoplasm or other&#xD;
             complications discovered during preoperative esophago-gastro-duodonoscopy.&#xD;
&#xD;
          -  revisional surgery&#xD;
&#xD;
          -  conversion to open procedure&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leonardo Claros, MD</last_name>
    <phone>4844262600</phone>
    <email>Leonardo.Claros@sluhn.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Luke's University and Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Leonardo Claros</last_name>
      <phone>484-426-2600</phone>
      <email>Leonardo.Claros@sluhn.org</email>
    </contact>
    <investigator>
      <last_name>Leonardo Claros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maher ElChaar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.visigi.com</url>
    <description>ViSiGi web site</description>
  </link>
  <reference>
    <citation>Satiani B, Bonner JT, Stone HH. Factors influencing intraoperative gastric regurgitation: a prospective random study of nasogastric tube drainage. Arch Surg. 1978 Jun;113(6):721-3.</citation>
    <PMID>26318</PMID>
  </reference>
  <reference>
    <citation>Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy--influence of sleeve size and resected gastric volume. Obes Surg. 2007 Oct;17(10):1297-305.</citation>
    <PMID>18098398</PMID>
  </reference>
  <reference>
    <citation>Abu-Gazala S, Donchin Y, Keidar A. Nasogastric tube, temperature probe, and bougie stapling during bariatric surgery: a multicenter survey. Surg Obes Relat Dis. 2012 Sep-Oct;8(5):595-600; discussion 600-1. doi: 10.1016/j.soard.2011.08.017. Epub 2011 Aug 31.</citation>
    <PMID>21963196</PMID>
  </reference>
  <reference>
    <citation>Péquignot A, Dhahria A, Mensah E, Verhaeghe P, Badaoui R, Sabbagh C, Regimbeau JM. Stapling and Section of the Nasogastric Tube during Sleeve Gastrectomy: How to Prevent and Recover? Case Rep Gastroenterol. 2011;5(2):350-4. doi: 10.1159/000329706. Epub 2011 Jul 6.</citation>
    <PMID>21769286</PMID>
  </reference>
  <reference>
    <citation>Sanchez BS, Safadi BY, Kieran JA, Hsu GP, Brodsky JB, Curet MJ, Morton JM. Orogastric tube complications in laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006 Apr;16(4):443-7.</citation>
    <PMID>16608608</PMID>
  </reference>
  <reference>
    <citation>Vennes JA. Infectious complications of gastrointestinal endoscopy. Dig Dis Sci. 1981 Jul;26(7 Suppl):60S-64S. Review.</citation>
    <PMID>6765053</PMID>
  </reference>
  <reference>
    <citation>Kovaleva J, Peters FT, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013 Apr;26(2):231-54. doi: 10.1128/CMR.00085-12. Review.</citation>
    <PMID>23554415</PMID>
  </reference>
  <reference>
    <citation>Schembre DB. Infectious complications associated with gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 2000 Apr;10(2):215-32. Review.</citation>
    <PMID>10683209</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>December 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2013</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Luke's Hospital and Health Network, Pennsylvania</investigator_affiliation>
    <investigator_full_name>Leonardo Claros</investigator_full_name>
    <investigator_title>Bariatric Section Chief and Program Director</investigator_title>
  </responsible_party>
  <keyword>ViSiGi</keyword>
  <keyword>Calibration tube</keyword>
  <keyword>Sleeve gastrectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

